HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ALPHAMAB-B

8.330

-0.120-1.42%

Volume:841.00K

Turnover:6.93M

Market Cap:8.06B

PE:-59.40

High:8.400

Open:8.305

Low:8.120

Close:8.450

52wk High:15.750

52wk Low:6.230

Shares:968.00M

HK Float Shares:968.00M

Volume Ratio:0.89

T/O Rate:0.09%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.140

ROE:-9.98%

ROA:-5.47%

PB:4.12

PE(LYR):-59.40

PS:13.32

Loading ...

Overview Company News Filings

Why Alphamab Oncology (SEHK:9966) Is Up 9.2% After Priority Review For Anbenitamab In HER2 Breast Cancer

Simply Wall St.

Alphamab Oncology Reports RMB40.46 Million 1H26 Loss Amid 15% Revenue Drop; Cash at RMB1.43 Billion Supports Expanding Oncology Pipeline

Bulletin Express

Alphamab Oncology Swings to FY26 H1 Loss of RMB 40.46 Million; Revenue Falls 15.09% to RMB 271.24 Million

HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%

Tiger Newspress

Alphamab's KN026 Combination Therapy for First-Line HER2-Positive Advanced Breast Cancer Receives NMPA Filing Acceptance

Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer

Alphamab Oncology - Nmpa Accepts Nda for Anbenitamab (Kn026) with Hb1801 for Her2+ Advanced Breast Cancer

THOMSON REUTERS

Alphamab Oncology Schedules Board Meeting to Review Interim Results

Alphamab Oncology Licenses Cancer Drug Candidate to Pathos AI for Up to $2.09 Billion

MT Newswires Live

Alphamab Oncology (ALPHAMAB-B) Reports Stable Share Capital and Option Movements for July 2026

Bulletin Express

CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China

MT Newswires Live

ALPHAMAB-B's Novel Drug Application for Anniutuo (KN026) in HER2-Positive Breast Cancer Neoadjuvant Therapy Accepted by Chinese Regulator

Alphamab Oncology receives NMPA priority review for Anbenitamab NDA in neoadjuvant HER2+ breast-cancer therapy

Bulletin Express

Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)

Alphamab Oncology - Nmpa Accepts Nda for Anbenitamab (Kn026) as Neoadjuvant Her2+ Breast Cancer Treatment

THOMSON REUTERS

HK-Listed Alphamab Hits 2-Month High on Breast Cancer Drug Licensing Deal

ALPHAMAB-B Surges Over 12% in Morning Trade Following $2.1 Billion TROP2/HER3 Dual Antibody ADC Export Licensing Deal

Alphamab Oncology - Jiangsu Alphamab to Receive $125 Mln Upfront, up to $2.09 Bln Total from Pathos AI

THOMSON REUTERS

Alphamab Oncology - Unit Granted Pathos AI Exclusive License to Commercialize Jskn016 in Territories Outside Chinese Mainland, HK, Macau, Taiwan

THOMSON REUTERS

Alphamab Oncology Licenses Jskn016 Ex-China Rights to Pathos AI for up to USD 2.09 Billion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/09966/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"09966","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09966\",,,,,undefined,":{"symbol":"09966","market":"HK","secType":"STK","nameCN":"ALPHAMAB-B","latestPrice":8.33,"timestamp":1789027724006,"preClose":8.45,"halted":0,"volume":841000,"delay":0,"changeRate":-0.014201183431952572,"floatShares":968000000,"shares":968000000,"eps":-0.14022080732678854,"marketStatus":"Closed","change":-0.12,"latestTime":"09-10 16:08:44","open":8.305,"high":8.4,"low":8.12,"amount":6931016,"amplitude":0.033136,"askPrice":8.34,"askSize":1000,"bidPrice":8.3,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.2131554917510899,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789090200000},"marketStatusCode":5,"adr":0,"listingDate":1576080000000,"exchange":"SEHK","adjPreClose":8.45,"openAndCloseTimeList":[[1789003800000,1789012800000],[1789016400000,1789027200000]],"volumeRatio":0.892402,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"09966\",,,,,undefined,":{"symbol":"09966","floatShares":968000000,"roa":"-5.47%","roe":"-9.98%","lyrEps":-0.140225,"volumeRatio":0.892402,"shares":968000000,"dividePrice":0,"high":8.4,"amplitude":0.033136,"preClose":8.45,"low":8.12,"week52Low":6.23,"pbRate":"4.12","psRate":"13.32","week52High":15.75,"institutionHeld":0,"latestPrice":8.33,"eps":-0.14022457108804062,"divideRate":0,"volume":841000,"delay":0,"ttmEps":-0.21316121320139256,"open":8.305,"prevYearClose":9.8,"prevWeekClose":8.77,"prevMonthClose":8.965,"prevQuarterClose":6.95,"fiveDayClose":8.86,"twentyDayClose":8.45,"sixtyDayClose":6.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/09966\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"09966","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"market":"HK","date":"2026-03-25","symbol":"09966","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774368000000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-28","symbol":"09966","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756344600000,"name":null,"time":"","dateTimestamp":1756310400000,"actualEps":null},{"date":"2025-03-25","symbol":"09966","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742866200000,"name":null,"time":"Post-Mkt","dateTimestamp":1742832000000,"actualEps":null},{"date":"2024-08-15","symbol":"09966","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723685400000,"name":null,"time":"Post-Mkt","dateTimestamp":1723651200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"09966\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"09966\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":3,"updateTime":1769184000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/09966\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"09966","date":"2026-09-09","current":-39.051236,"percent":0.148902,"low":-88.862928,"twenty":-34.670805,"median":-17.873419,"eighty":28.196225,"high":58.684884,"avg":-12.810321,"sd":30.491513,"marketCap":8183881589},"quantilePoints":[{"date":"2021-09-10","current":-30.382936,"twenty":-39.401539,"median":-26.640453,"eighty":-12.799389,"marketCap":21711409584},{"date":"2021-09-17","current":-26.992304,"twenty":-39.104645,"median":-26.783416,"eighty":-12.828856,"marketCap":19231442541},{"date":"2021-09-24","current":-24.472208,"twenty":-38.971499,"median":-26.752109,"eighty":-12.847091,"marketCap":17443994596},{"date":"2021-09-30","current":-23.082076,"twenty":-38.810991,"median":-26.645817,"eighty":-12.874922,"marketCap":16508157976},{"date":"2021-10-08","current":-22.481188,"twenty":-38.703179,"median":-26.190542,"eighty":-12.957107,"marketCap":16077673131},{"date":"2021-10-15","current":-22.073477,"twenty":-38.672506,"median":-25.693365,"eighty":-13.062755,"marketCap":15796922145},{"date":"2021-10-22","current":-23.032708,"twenty":-38.647454,"median":-24.836506,"eighty":-13.216108,"marketCap":16601741638},{"date":"2021-10-29","current":-20.929201,"twenty":-38.590118,"median":-24.43195,"eighty":-13.328983,"marketCap":15048252849},{"date":"2021-11-05","current":-19.049585,"twenty":-38.456765,"median":-23.785332,"eighty":-13.397234,"marketCap":13719364849},{"date":"2021-11-12","current":-21.352494,"twenty":-38.349074,"median":-23.685099,"eighty":-13.500511,"marketCap":15441304230},{"date":"2021-11-19","current":-23.559904,"twenty":-38.09836,"median":-23.566387,"eighty":-13.594759,"marketCap":17013509751},{"date":"2021-11-26","current":-24.796984,"twenty":-37.741225,"median":-23.751485,"eighty":-13.636547,"marketCap":17912582806},{"date":"2021-12-03","current":-23.432191,"twenty":-37.532346,"median":-23.768698,"eighty":-13.650686,"marketCap":16957993754},{"date":"2021-12-10","current":-21.429631,"twenty":-37.255577,"median":-23.601157,"eighty":-13.734345,"marketCap":15535211631},{"date":"2021-12-17","current":-17.822954,"twenty":-37.096113,"median":-23.511847,"eighty":-13.85618,"marketCap":12911653575},{"date":"2021-12-24","current":-17.909322,"twenty":-36.853053,"median":-23.44502,"eighty":-13.888948,"marketCap":12986612377},{"date":"2021-12-31","current":-17.535218,"twenty":-36.556554,"median":-23.429856,"eighty":-13.94459,"marketCap":12742996272},{"date":"2022-01-07","current":-15.893614,"twenty":-17.170858,"median":-16.499144,"eighty":-15.831692,"marketCap":11506176045},{"date":"2022-01-14","current":-16.943897,"twenty":-17.170858,"median":-16.521118,"eighty":-16.202208,"marketCap":12293243462},{"date":"2022-01-21","current":-16.029012,"twenty":-17.088796,"median":-16.543092,"eighty":-16.256367,"marketCap":11656093648},{"date":"2022-01-28","current":-12.285046,"twenty":-17.06511,"median":-16.479323,"eighty":-15.418562,"marketCap":8910727540},{"date":"2022-02-04","current":-12.601255,"twenty":-17.064989,"median":-16.436633,"eighty":-13.889332,"marketCap":9135603945},{"date":"2022-02-11","current":-12.640346,"twenty":-17.064,"median":-16.029012,"eighty":-13.029958,"marketCap":9182453196},{"date":"2022-02-18","current":-12.116498,"twenty":-16.945463,"median":-15.716538,"eighty":-12.878125,"marketCap":8845138588},{"date":"2022-02-25","current":-12.112309,"twenty":-16.943897,"median":-13.889332,"eighty":-12.601255,"marketCap":8863878289},{"date":"2022-03-04","current":-10.48082,"twenty":-16.543092,"median":-13.037325,"eighty":-12.112309,"marketCap":7672881063},{"date":"2022-03-11","current":-9.328946,"twenty":-16.517271,"median":-13.027408,"eighty":-11.794703,"marketCap":6819296495},{"date":"2022-03-18","current":-10.345437,"twenty":-16.499144,"median":-12.881139,"eighty":-11.440921,"marketCap":7532180310},{"date":"2022-03-25","current":-10.293471,"twenty":-16.459503,"median":-12.785641,"eighty":-10.48082,"marketCap":7494660109},{"date":"2022-04-01","current":-14.297066,"twenty":-16.413764,"median":-12.859655,"eighty":-10.48082,"marketCap":7260158854},{"date":"2022-04-08","current":-15.491011,"twenty":-16.409102,"median":-12.884734,"eighty":-10.570438,"marketCap":7869862117},{"date":"2022-04-14","current":-13.574781,"twenty":-16.284169,"median":-13.028683,"eighty":-10.933821,"marketCap":6884956846},{"date":"2022-04-22","current":-12.815632,"twenty":-16.132599,"median":-12.892105,"eighty":-11.273053,"marketCap":6378434136},{"date":"2022-04-29","current":-15.496239,"twenty":-15.992174,"median":-12.898894,"eighty":-11.449013,"marketCap":7588460611},{"date":"2022-05-06","current":-14.409179,"twenty":-15.928257,"median":-13.029958,"eighty":-11.46436,"marketCap":6997517449},{"date":"2022-05-13","current":-13.039318,"twenty":-15.893614,"median":-13.039318,"eighty":-11.477201,"marketCap":6218973282},{"date":"2022-05-20","current":-14.565659,"twenty":-15.738809,"median":-13.068955,"eighty":-11.584492,"marketCap":7044417700},{"date":"2022-05-27","current":-12.908885,"twenty":-15.694268,"median":-13.170134,"eighty":-11.742961,"marketCap":6237733383},{"date":"2022-06-02","current":-15.137652,"twenty":-15.684864,"median":-13.379031,"eighty":-11.784355,"marketCap":7353959356},{"date":"2022-06-10","current":-16.505757,"twenty":-15.940348,"median":-13.514449,"eighty":-11.948913,"marketCap":7964685112},{"date":"2022-06-17","current":-15.374218,"twenty":-15.902275,"median":-13.574781,"eighty":-12.01146,"marketCap":7410538389},{"date":"2022-06-24","current":-18.243922,"twenty":-16.040638,"median":-13.677347,"eighty":-12.020595,"marketCap":8828778309},{"date":"2022-06-30","current":-15.728498,"twenty":-16.132948,"median":-13.734552,"eighty":-12.075937,"marketCap":7598384736},{"date":"2022-07-08","current":-15.401573,"twenty":-16.213925,"median":-14.214649,"eighty":-12.114822,"marketCap":7448107658},{"date":"2022-07-15","current":-13.957754,"twenty":-16.132948,"median":-14.253329,"eighty":-12.158169,"marketCap":6687329953},{"date":"2022-07-22","current":-13.556788,"twenty":-16.052264,"median":-13.957754,"eighty":-12.241614,"marketCap":6499483606},{"date":"2022-07-29","current":-12.816298,"twenty":-15.984046,"median":-13.734552,"eighty":-12.282517,"marketCap":6151967864},{"date":"2022-08-05","current":-12.849025,"twenty":-15.951796,"median":-13.67889,"eighty":-12.241614,"marketCap":6151967864},{"date":"2022-08-12","current":-12.126293,"twenty":-15.942263,"median":-13.653572,"eighty":-12.13744,"marketCap":5813844439},{"date":"2022-08-19","current":-11.754194,"twenty":-15.910936,"median":-13.561425,"eighty":-12.101504,"marketCap":5579036505},{"date":"2022-08-26","current":-14.820088,"twenty":-15.819231,"median":-13.568103,"eighty":-12.114822,"marketCap":6978491791},{"date":"2022-09-02","current":-23.46609,"twenty":-15.942263,"median":-13.639619,"eighty":-12.119419,"marketCap":7805015717},{"date":"2022-09-09","current":-22.421914,"twenty":-16.132948,"median":-13.677347,"eighty":-12.124322,"marketCap":7429323023},{"date":"2022-09-16","current":-20.513842,"twenty":-16.411433,"median":-13.695704,"eighty":-12.133724,"marketCap":6734291539},{"date":"2022-09-23","current":-18.727552,"twenty":-16.482452,"median":-13.764182,"eighty":-12.145399,"marketCap":6029867738},{"date":"2022-09-30","current":-17.760163,"twenty":-16.512665,"median":-14.086201,"eighty":-12.162095,"marketCap":5729313583},{"date":"2022-10-07","current":-17.557368,"twenty":-16.549697,"median":-14.253329,"eighty":-12.200956,"marketCap":5663567362},{"date":"2022-10-14","current":-18.422453,"twenty":-17.040293,"median":-14.409179,"eighty":-12.26158,"marketCap":5879590661},{"date":"2022-10-21","current":-18.312429,"twenty":-17.110066,"median":-14.521212,"eighty":-12.266929,"marketCap":5804452122},{"date":"2022-10-28","current":-16.711302,"twenty":-17.217664,"median":-14.625046,"eighty":-12.279988,"marketCap":5287874668},{"date":"2022-11-04","current":-22.018013,"twenty":-17.339043,"median":-14.652332,"eighty":-12.287313,"marketCap":7034845695},{"date":"2022-11-11","current":-21.415614,"twenty":-17.446229,"median":-14.695745,"eighty":-12.339559,"marketCap":6903353252},{"date":"2022-11-18","current":-27.349007,"twenty":-17.693119,"median":-14.898563,"eighty":-12.519492,"marketCap":8785789555},{"date":"2022-11-25","current":-23.765769,"twenty":-17.972543,"median":-14.987518,"eighty":-12.558957,"marketCap":7574114079},{"date":"2022-12-02","current":-26.174182,"twenty":-18.335139,"median":-15.067608,"eighty":-12.605734,"marketCap":8485638974},{"date":"2022-12-09","current":-28.776484,"twenty":-18.700907,"median":-15.204594,"eighty":-12.62699,"marketCap":9415958197},{"date":"2022-12-16","current":-29.361916,"twenty":-19.228432,"median":-15.373796,"eighty":-12.660178,"marketCap":9585107147},{"date":"2022-12-23","current":-29.065003,"twenty":-19.518662,"median":-15.491011,"eighty":-12.748732,"marketCap":9491135508},{"date":"2022-12-30","current":-30.706351,"twenty":-20.691058,"median":-15.537108,"eighty":-12.776414,"marketCap":10148936979},{"date":"2023-01-06","current":-34.446644,"twenty":-21.092014,"median":-15.642909,"eighty":-12.803636,"marketCap":11502128576},{"date":"2023-01-13","current":-37.5558,"twenty":-22.093247,"median":-15.694268,"eighty":-12.816032,"marketCap":12780142863},{"date":"2023-01-20","current":-34.984086,"twenty":-22.45467,"median":-15.754226,"eighty":-12.83123,"marketCap":11802837820},{"date":"2023-01-27","current":-36.369324,"twenty":-23.121815,"median":-15.831629,"eighty":-12.841184,"marketCap":12272696014},{"date":"2023-02-03","current":-44.714918,"twenty":-23.888047,"median":-15.950281,"eighty":-12.849025,"marketCap":15167022486},{"date":"2023-02-10","current":-41.260502,"twenty":-24.093097,"median":-16.058077,"eighty":-12.878125,"marketCap":13911210300},{"date":"2023-02-17","current":-40.325712,"twenty":-25.009317,"median":-16.232327,"eighty":-12.884153,"marketCap":13467440762},{"date":"2023-02-24","current":-41.468197,"twenty":-25.82041,"median":-16.421267,"eighty":-12.885315,"marketCap":13679678367},{"date":"2023-03-03","current":-43.817626,"twenty":-27.026978,"median":-16.467172,"eighty":-12.898894,"marketCap":14547923115},{"date":"2023-03-10","current":-38.640155,"twenty":-41.544229,"median":-39.606335,"eighty":-38.921385,"marketCap":12734256308},{"date":"2023-03-17","current":-45.981837,"twenty":-36.747123,"median":-18.243922,"eighty":-13.756749,"marketCap":15300401897},{"date":"2023-03-24","current":-41.160417,"twenty":-37.327637,"median":-18.28036,"eighty":-13.766939,"marketCap":13853327317},{"date":"2023-03-31","current":-38.068943,"twenty":-38.013012,"median":-18.315502,"eighty":-13.778887,"marketCap":12714961980},{"date":"2023-04-06","current":-43.295967,"twenty":-38.403453,"median":-18.336928,"eighty":-13.781651,"marketCap":14451451477},{"date":"2023-04-14","current":-43.747506,"twenty":-38.561286,"median":-18.405859,"eighty":-13.793666,"marketCap":16284412612},{"date":"2023-04-21","current":-39.932363,"twenty":-38.703179,"median":-18.48348,"eighty":-13.816299,"marketCap":14856632359},{"date":"2023-04-28","current":-39.970681,"twenty":-39.225939,"median":-18.621321,"eighty":-13.840508,"marketCap":14760160721},{"date":"2023-05-05","current":-40.166061,"twenty":-39.290038,"median":-18.683461,"eighty":-13.852302,"marketCap":14856632359},{"date":"2023-05-12","current":-36.925364,"twenty":-39.290038,"median":-18.774651,"eighty":-13.85982,"marketCap":13563912401},{"date":"2023-05-19","current":-24.719387,"twenty":-39.117221,"median":-18.879869,"eighty":-13.865832,"marketCap":8952568071},{"date":"2023-05-25","current":-23.29845,"twenty":-39.108027,"median":-18.921163,"eighty":-13.869727,"marketCap":8403228460},{"date":"2023-06-02","current":-21.901518,"twenty":-39.071359,"median":-18.943448,"eighty":-13.885174,"marketCap":7872599797},{"date":"2023-06-09","current":-20.454824,"twenty":-38.924331,"median":-19.035121,"eighty":-13.891345,"marketCap":7341971135},{"date":"2023-06-16","current":-22.146741,"twenty":-38.853024,"median":-19.126864,"eighty":-13.899678,"marketCap":7911190973},{"date":"2023-06-23","current":-18.955124,"twenty":-38.789903,"median":-19.149261,"eighty":-13.900804,"marketCap":6734160121},{"date":"2023-06-30","current":-20.498364,"twenty":-38.749431,"median":-19.291559,"eighty":-13.923916,"marketCap":7216549814},{"date":"2023-07-07","current":-25.123882,"twenty":-38.726176,"median":-19.347276,"eighty":-13.932185,"marketCap":8827731391},{"date":"2023-07-14","current":-25.317769,"twenty":-38.687847,"median":-19.399951,"eighty":-13.94759,"marketCap":9020687268},{"date":"2023-07-21","current":-25.381576,"twenty":-38.649495,"median":-19.466605,"eighty":-13.957754,"marketCap":9001391680},{"date":"2023-07-28","current":-27.451279,"twenty":-38.644392,"median":-19.47828,"eighty":-13.964689,"marketCap":9724976220},{"date":"2023-08-04","current":-23.653749,"twenty":-38.640155,"median":-19.530791,"eighty":-13.983912,"marketCap":8393580666},{"date":"2023-08-11","current":-21.299887,"twenty":-38.508707,"median":-19.571912,"eighty":-14.027277,"marketCap":7515631424},{"date":"2023-08-18","current":-19.250306,"twenty":-38.506952,"median":-19.585154,"eighty":-14.027284,"marketCap":6743807915},{"date":"2023-08-25","current":-32.203663,"twenty":-38.501855,"median":-19.663677,"eighty":-14.080878,"marketCap":7563870394},{"date":"2023-09-01","current":-35.302101,"twenty":-38.378852,"median":-19.736206,"eighty":-14.101892,"marketCap":8326046109},{"date":"2023-09-08","current":-34.605021,"twenty":-38.304408,"median":-19.857796,"eighty":-14.114833,"marketCap":8065555675},{"date":"2023-09-15","current":-37.542629,"twenty":-38.132108,"median":-19.912369,"eighty":-14.137969,"marketCap":8818083597},{"date":"2023-09-22","current":-38.573862,"twenty":-38.378852,"median":-20.085413,"eighty":-14.152594,"marketCap":9020687268},{"date":"2023-09-29","current":-35.418957,"twenty":-38.378852,"median":-20.217001,"eighty":-14.161696,"marketCap":8297102728},{"date":"2023-10-06","current":-35.229903,"twenty":-38.322726,"median":-20.283173,"eighty":-14.166678,"marketCap":8248863758},{"date":"2023-10-13","current":-40.523415,"twenty":-38.502874,"median":-20.44317,"eighty":-14.173688,"marketCap":9474133580},{"date":"2023-10-20","current":-39.594032,"twenty":-38.521738,"median":-20.486571,"eighty":-14.206745,"marketCap":9242586527},{"date":"2023-10-27","current":-47.54977,"twenty":-38.64185,"median":-20.513842,"eighty":-14.216906,"marketCap":11094962950},{"date":"2023-11-03","current":-48.331086,"twenty":-38.735478,"median":-20.568945,"eighty":-14.224134,"marketCap":11307214415},{"date":"2023-11-10","current":-53.868252,"twenty":-39.004786,"median":-20.622682,"eighty":-14.233193,"marketCap":12600018794},{"date":"2023-11-17","current":-25.63055,"twenty":-39.106336,"median":-20.683961,"eighty":-14.258177,"marketCap":6049166756},{"date":"2023-11-24","current":-27.205215,"twenty":-39.004786,"median":-20.741333,"eighty":-14.276226,"marketCap":6473669686},{"date":"2023-12-01","current":-25.600638,"twenty":-38.896568,"median":-20.808578,"eighty":-14.289723,"marketCap":6117109736},{"date":"2023-12-08","current":-25.866704,"twenty":-38.821463,"median":-20.929201,"eighty":-14.323551,"marketCap":6155703488},{"date":"2023-12-15","current":-26.927511,"twenty":-38.76562,"median":-20.967194,"eighty":-14.351434,"marketCap":6445156630},{"date":"2023-12-22","current":-25.009304,"twenty":-38.735478,"median":-21.013037,"eighty":-14.35931,"marketCap":5982031603},{"date":"2023-12-29","current":-26.642107,"twenty":-38.71851,"median":-21.050342,"eighty":-14.361696,"marketCap":6406562878},{"date":"2024-01-05","current":-24.972539,"twenty":-38.687847,"median":-21.103846,"eighty":-14.368415,"marketCap":5962734727},{"date":"2024-01-12","current":-24.595768,"twenty":-38.649495,"median":-21.157012,"eighty":-14.402891,"marketCap":5875898784},{"date":"2024-01-19","current":-19.938246,"twenty":-38.644392,"median":-21.228449,"eighty":-14.409179,"marketCap":4756679968},{"date":"2024-01-26","current":-18.554521,"twenty":-38.640155,"median":-21.10942,"eighty":-14.411483,"marketCap":4409336197},{"date":"2024-02-02","current":-16.464276,"twenty":-38.588501,"median":-21.050342,"eighty":-14.423239,"marketCap":3907617418},{"date":"2024-02-09","current":-17.233111,"twenty":-38.573862,"median":-20.972717,"eighty":-14.434059,"marketCap":4110234617},{"date":"2024-02-16","current":-18.402278,"twenty":-38.534769,"median":-20.967194,"eighty":-14.439295,"marketCap":4390039321},{"date":"2024-02-23","current":-19.760229,"twenty":-38.507654,"median":-20.929201,"eighty":-14.453404,"marketCap":4689140902},{"date":"2024-03-01","current":-19.95108,"twenty":-38.503894,"median":-20.872963,"eighty":-14.464872,"marketCap":4737383092},{"date":"2024-03-08","current":-18.926824,"twenty":-38.428053,"median":-20.756308,"eighty":-14.480891,"marketCap":4496172140},{"date":"2024-03-15","current":-21.138772,"twenty":-38.336758,"median":-20.808578,"eighty":-14.489737,"marketCap":5017187796},{"date":"2024-03-22","current":-18.228539,"twenty":-38.306123,"median":-20.756308,"eighty":-14.50055,"marketCap":4322500255},{"date":"2024-03-28","current":-18.491125,"twenty":-38.279384,"median":-20.741333,"eighty":-14.518511,"marketCap":4370742445},{"date":"2024-04-05","current":-17.315482,"twenty":-38.241849,"median":-20.708906,"eighty":-14.534718,"marketCap":3946211170},{"date":"2024-04-12","current":-19.505885,"twenty":-38.177223,"median":-20.641249,"eighty":-14.539083,"marketCap":4447929950},{"date":"2024-04-19","current":-17.235745,"twenty":-38.132108,"median":-20.593675,"eighty":-14.549119,"marketCap":3926914294},{"date":"2024-04-26","current":-19.801056,"twenty":-38.068943,"median":-20.560672,"eighty":-14.563882,"marketCap":4505820578},{"date":"2024-05-03","current":-22.021106,"twenty":-38.043702,"median":-20.560672,"eighty":-14.565304,"marketCap":5007539358},{"date":"2024-05-10","current":-22.138266,"twenty":-38.000701,"median":-20.593675,"eighty":-14.571149,"marketCap":5046133110},{"date":"2024-05-17","current":-21.882428,"twenty":-37.938675,"median":-20.631965,"eighty":-14.596889,"marketCap":4980496851},{"date":"2024-05-24","current":-19.842196,"twenty":-37.865243,"median":-20.622682,"eighty":-14.620281,"marketCap":4505820578},{"date":"2024-05-31","current":-10.782036,"twenty":-37.809484,"median":-20.568945,"eighty":-14.569777,"marketCap":2450906469},{"date":"2024-06-07","current":-12.112976,"twenty":-37.717193,"median":-20.522014,"eighty":-14.537337,"marketCap":2750032849},{"date":"2024-06-14","current":-11.400893,"twenty":-37.653981,"median":-20.498364,"eighty":-14.489697,"marketCap":2585995802},{"date":"2024-06-21","current":-10.998512,"twenty":-37.601075,"median":-20.467365,"eighty":-14.43755,"marketCap":2489503422},{"date":"2024-06-28","current":-10.23542,"twenty":-37.550532,"median":-20.444852,"eighty":-14.405406,"marketCap":2315817136},{"date":"2024-07-05","current":-9.939046,"twenty":-37.533657,"median":-20.379051,"eighty":-14.358604,"marketCap":2248272470},{"date":"2024-07-12","current":-9.967061,"twenty":-37.482408,"median":-20.291848,"eighty":-14.273743,"marketCap":2257921708},{"date":"2024-07-19","current":-9.498347,"twenty":-37.402324,"median":-20.229766,"eighty":-14.215401,"marketCap":2151780089},{"date":"2024-07-26","current":-9.208575,"twenty":-37.327637,"median":-20.193614,"eighty":-14.154414,"marketCap":2093884661},{"date":"2024-08-02","current":-9.723471,"twenty":-37.32352,"median":-20.137385,"eighty":-14.085081,"marketCap":2209675518},{"date":"2024-08-09","current":-9.785633,"twenty":-37.276776,"median":-20.11618,"eighty":-13.968534,"marketCap":2238623232},{"date":"2024-08-16","current":-10.459398,"twenty":-37.131301,"median":-20.033441,"eighty":-13.92557,"marketCap":2450906469},{"date":"2024-08-23","current":-9.595269,"twenty":-37.054596,"median":-19.957659,"eighty":-13.885174,"marketCap":2257921708},{"date":"2024-08-30","current":-10.057543,"twenty":-37.014228,"median":-19.927086,"eighty":-13.851089,"marketCap":2382591163},{"date":"2024-09-06","current":-9.272587,"twenty":-36.98439,"median":-19.877354,"eighty":-13.778887,"marketCap":2197696119},{"date":"2024-09-13","current":-10.071667,"twenty":-36.894129,"median":-19.843829,"eighty":-13.713216,"marketCap":2380837463},{"date":"2024-09-20","current":-10.781754,"twenty":-36.769187,"median":-19.822249,"eighty":-13.694027,"marketCap":2563978806},{"date":"2024-09-27","current":-12.328923,"twenty":-36.726748,"median":-19.766991,"eighty":-13.667525,"marketCap":2949539529},{"date":"2024-10-04","current":-19.265835,"twenty":-36.672442,"median":-19.722789,"eighty":-13.668964,"marketCap":4588172601},{"date":"2024-10-10","current":-17.028579,"twenty":-36.626927,"median":-19.702627,"eighty":-13.673211,"marketCap":4029109553},{"date":"2024-10-18","current":-16.380704,"twenty":-36.583892,"median":-19.632926,"eighty":-13.677655,"marketCap":3855607228},{"date":"2024-10-25","current":-16.381742,"twenty":-36.520467,"median":-19.62099,"eighty":-13.687972,"marketCap":3855607228},{"date":"2024-11-01","current":-15.01467,"twenty":-36.416733,"median":-19.585154,"eighty":-13.696039,"marketCap":3536235131},{"date":"2024-11-08","current":-16.963396,"twenty":-36.363867,"median":-19.546761,"eighty":-13.701906,"marketCap":3977073562},{"date":"2024-11-15","current":-19.884819,"twenty":-36.278398,"median":-19.531887,"eighty":-13.707553,"marketCap":4612634955},{"date":"2024-11-22","current":-18.108329,"twenty":-36.210789,"median":-19.505972,"eighty":-13.721035,"marketCap":4198557078},{"date":"2024-11-29","current":-15.834641,"twenty":-36.188592,"median":-19.472152,"eighty":-13.744476,"marketCap":3668922584},{"date":"2024-12-06","current":-15.695605,"twenty":-36.08373,"median":-19.458841,"eighty":-13.760466,"marketCap":3628141712},{"date":"2024-12-13","current":-15.376556,"twenty":-35.741648,"median":-19.352594,"eighty":-13.764182,"marketCap":3551151967},{"date":"2024-12-20","current":-14.497713,"twenty":-35.546493,"median":-19.273329,"eighty":-13.764182,"marketCap":3329806452},{"date":"2024-12-27","current":-15.179905,"twenty":-35.418957,"median":-19.167386,"eighty":-13.764182,"marketCap":3483785941},{"date":"2025-01-03","current":-14.913703,"twenty":-35.25196,"median":-19.110348,"eighty":-13.764182,"marketCap":3426043632},{"date":"2025-01-10","current":-13.750925,"twenty":-34.933941,"median":-19.027831,"eighty":-13.754891,"marketCap":3146955808},{"date":"2025-01-17","current":-13.361676,"twenty":-34.446644,"median":-18.949286,"eighty":-13.704922,"marketCap":3060342346},{"date":"2025-01-24","current":-13.529011,"twenty":-34.269926,"median":-18.916804,"eighty":-13.694027,"marketCap":3118084654},{"date":"2025-01-28","current":-13.464721,"twenty":-34.170079,"median":-18.907538,"eighty":-13.67642,"marketCap":3118084654},{"date":"2025-02-07","current":-15.122505,"twenty":-33.185621,"median":-18.746316,"eighty":-13.668964,"marketCap":3483785941},{"date":"2025-02-14","current":-16.67621,"twenty":-32.529754,"median":-18.691754,"eighty":-13.668964,"marketCap":3839863509},{"date":"2025-02-21","current":-18.324448,"twenty":-31.716657,"median":-18.612372,"eighty":-13.668964,"marketCap":4234435950},{"date":"2025-02-28","current":-24.569098,"twenty":-30.791932,"median":-18.612372,"eighty":-13.668964,"marketCap":5658746225},{"date":"2025-03-07","current":-25.261571,"twenty":-30.029344,"median":-18.603349,"eighty":-13.668604,"marketCap":5841596868},{"date":"2025-03-14","current":-23.047481,"twenty":-28.794501,"median":-18.603349,"eighty":-13.668604,"marketCap":5331539810},{"date":"2025-03-21","current":-30.797536,"twenty":-28.744886,"median":-18.603349,"eighty":-13.668604,"marketCap":7121551371},{"date":"2025-03-28","current":44.165917,"twenty":-28.393605,"median":-18.522823,"eighty":-13.656111,"marketCap":7862577663},{"date":"2025-04-03","current":42.845017,"twenty":-28.217133,"median":-18.487302,"eighty":-13.645978,"marketCap":7612360993},{"date":"2025-04-11","current":34.734253,"twenty":-28.217133,"median":-18.487302,"eighty":-13.613827,"marketCap":6130308410},{"date":"2025-04-17","current":36.065457,"twenty":-28.158527,"median":-18.48348,"eighty":-13.574068,"marketCap":6380525080},{"date":"2025-04-25","current":37.556149,"twenty":-28.275738,"median":-18.491125,"eighty":-13.557411,"marketCap":6649989186},{"date":"2025-05-02","current":42.574598,"twenty":-28.217133,"median":-18.487302,"eighty":-13.526841,"marketCap":7554618684},{"date":"2025-05-09","current":39.514662,"twenty":-28.275738,"median":-18.491125,"eighty":-13.490846,"marketCap":7060873063},{"date":"2025-05-16","current":35.776948,"twenty":-28.275738,"median":-18.453232,"eighty":-13.440013,"marketCap":6445211106},{"date":"2025-05-23","current":47.38287,"twenty":-28.275738,"median":-18.402278,"eighty":-13.368618,"marketCap":8561549082},{"date":"2025-05-30","current":47.34521,"twenty":-28.275738,"median":-18.33304,"eighty":-13.277541,"marketCap":8592354976},{"date":"2025-06-06","current":42.147937,"twenty":-28.275738,"median":-18.299422,"eighty":-13.14218,"marketCap":7668652761},{"date":"2025-06-13","current":42.289865,"twenty":-28.275738,"median":-18.27405,"eighty":-13.070276,"marketCap":7697518456},{"date":"2025-06-20","current":35.964015,"twenty":-28.275738,"median":-18.27405,"eighty":-13.029979,"marketCap":6533268789},{"date":"2025-06-27","current":32.483216,"twenty":-28.217133,"median":-18.185823,"eighty":-12.946884,"marketCap":5917467313},{"date":"2025-07-04","current":34.066162,"twenty":-28.217133,"median":-18.046648,"eighty":-12.88485,"marketCap":6206124255},{"date":"2025-07-11","current":36.268142,"twenty":-28.217133,"median":-18.029621,"eighty":-12.840289,"marketCap":6600622076},{"date":"2025-07-18","current":45.76756,"twenty":-28.217133,"median":-18.029621,"eighty":-12.796764,"marketCap":8322941830},{"date":"2025-07-25","current":48.635945,"twenty":-28.217133,"median":-18.029621,"eighty":-12.69525,"marketCap":8876728670},{"date":"2025-08-01","current":50.491081,"twenty":-28.217133,"median":-18.029621,"eighty":-12.5376,"marketCap":9158375422},{"date":"2025-08-08","current":48.602584,"twenty":-28.217133,"median":-18.029621,"eighty":-12.398637,"marketCap":8837880842},{"date":"2025-08-15","current":48.140623,"twenty":-28.217133,"median":-18.029621,"eighty":-12.315906,"marketCap":8740761273},{"date":"2025-08-22","current":57.950472,"twenty":-28.217133,"median":-18.029621,"eighty":-12.254489,"marketCap":10488913527},{"date":"2025-08-29","current":49.451084,"twenty":-28.217133,"median":-18.029621,"eighty":-12.194762,"marketCap":8993272154},{"date":"2025-09-05","current":39.453945,"twenty":-28.217133,"median":-18.029621,"eighty":-12.124322,"marketCap":10032451550},{"date":"2025-09-12","current":47.42741,"twenty":-28.217133,"median":-18.029621,"eighty":-12.096265,"marketCap":12081674470},{"date":"2025-09-19","current":44.828603,"twenty":-28.217133,"median":-18.029621,"eighty":-12.019811,"marketCap":11411549439},{"date":"2025-09-26","current":46.934282,"twenty":-28.217133,"median":-18.029621,"eighty":-11.831972,"marketCap":11916571202},{"date":"2025-10-03","current":58.385068,"twenty":-28.158527,"median":-18.021599,"eighty":-11.755883,"marketCap":14859294164},{"date":"2025-10-10","current":49.909916,"twenty":-28.217133,"median":-18.029621,"eighty":-11.664242,"marketCap":12683815802},{"date":"2025-10-17","current":55.035469,"twenty":-28.217133,"median":-18.029621,"eighty":-11.470781,"marketCap":13975506079},{"date":"2025-10-24","current":45.261337,"twenty":-28.217133,"median":-18.029621,"eighty":-11.338351,"marketCap":11497678332},{"date":"2025-10-31","current":43.864804,"twenty":-28.217133,"median":-18.029621,"eighty":-11.156758,"marketCap":11159539015},{"date":"2025-11-07","current":36.144291,"twenty":-28.217133,"median":-18.029621,"eighty":-11.054596,"marketCap":9189637780},{"date":"2025-11-14","current":37.226268,"twenty":-28.217133,"median":-18.029621,"eighty":-10.962516,"marketCap":9491548883},{"date":"2025-11-21","current":37.509917,"twenty":-28.217133,"median":-18.029621,"eighty":-10.62574,"marketCap":9559414912},{"date":"2025-11-28","current":40.619308,"twenty":-28.217133,"median":-18.029621,"eighty":-10.506267,"marketCap":10389445551},{"date":"2025-12-05","current":41.722201,"twenty":-28.217133,"median":-18.029621,"eighty":-10.418991,"marketCap":10689886607},{"date":"2025-12-12","current":40.470968,"twenty":-28.217133,"median":-18.029621,"eighty":-10.328476,"marketCap":10388480751},{"date":"2025-12-19","current":41.091429,"twenty":-28.217133,"median":-18.029621,"eighty":-10.278072,"marketCap":10572604944},{"date":"2025-12-24","current":39.124027,"twenty":-28.217133,"median":-18.029621,"eighty":-10.261216,"marketCap":10097758342},{"date":"2026-01-02","current":35.829064,"twenty":-28.275738,"median":-18.037644,"eighty":-10.131708,"marketCap":9283735597},{"date":"2026-01-09","current":40.755473,"twenty":-28.275738,"median":-18.037644,"eighty":-10.049921,"marketCap":10586521438},{"date":"2026-01-16","current":37.910275,"twenty":-28.275738,"median":-18.037644,"eighty":-9.985778,"marketCap":9879461909},{"date":"2026-01-23","current":35.826131,"twenty":-28.275738,"median":-18.037644,"eighty":-9.870301,"marketCap":9327374332},{"date":"2026-01-30","current":32.996697,"twenty":-28.275738,"median":-18.037644,"eighty":-9.785633,"marketCap":8630000550},{"date":"2026-02-06","current":32.433,"twenty":-28.275738,"median":-18.037644,"eighty":-9.718873,"marketCap":8504085839},{"date":"2026-02-13","current":32.945618,"twenty":-28.217133,"median":-18.029621,"eighty":-9.613637,"marketCap":8688115032},{"date":"2026-02-20","current":33.839118,"twenty":-28.334344,"median":-18.046648,"eighty":-9.565339,"marketCap":8910887212},{"date":"2026-02-27","current":31.68928,"twenty":-28.334344,"median":-18.046648,"eighty":-9.509688,"marketCap":8436285610},{"date":"2026-03-06","current":28.792488,"twenty":-28.334344,"median":-18.046648,"eighty":-9.385032,"marketCap":7603311371},{"date":"2026-03-13","current":31.398747,"twenty":-28.334344,"median":-18.046648,"eighty":-9.277488,"marketCap":8329742394},{"date":"2026-03-20","current":30.601868,"twenty":-28.334344,"median":-18.046648,"eighty":-9.050312,"marketCap":8087598719},{"date":"2026-03-27","current":-57.808719,"twenty":-28.394262,"median":-17.932602,"eighty":20.857646,"marketCap":7458025166},{"date":"2026-04-02","current":-67.544334,"twenty":-28.812518,"median":-17.932602,"eighty":20.857646,"marketCap":8755915260},{"date":"2026-04-10","current":-69.622458,"twenty":-29.302533,"median":-17.932602,"eighty":20.857646,"marketCap":9094916404},{"date":"2026-04-17","current":-88.195901,"twenty":-30.2986,"median":-17.932602,"eighty":20.857646,"marketCap":11526038894},{"date":"2026-04-24","current":-83.151421,"twenty":-30.665238,"median":-17.932602,"eighty":20.857646,"marketCap":10867408100},{"date":"2026-04-30","current":-76.285681,"twenty":-30.923663,"median":-17.932602,"eighty":20.857646,"marketCap":9976319379},{"date":"2026-05-08","current":-74.05623,"twenty":-31.791607,"median":-17.909322,"eighty":28.135623,"marketCap":9714804210},{"date":"2026-05-15","current":-65.687804,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":8639686297},{"date":"2026-05-22","current":-69.01209,"twenty":-32.586236,"median":-17.932602,"eighty":20.857646,"marketCap":9056173416},{"date":"2026-05-29","current":-66.934096,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":8814029742},{"date":"2026-06-05","current":-51.045913,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":6731594144},{"date":"2026-06-12","current":-52.182919,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":6876880348},{"date":"2026-06-18","current":-53.671086,"twenty":-32.586236,"median":-17.932602,"eighty":20.857646,"marketCap":7089966782},{"date":"2026-06-26","current":-49.660978,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":6528193457},{"date":"2026-07-03","current":-56.17656,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":7390224938},{"date":"2026-07-10","current":-56.462771,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":7418761299},{"date":"2026-07-17","current":-51.047611,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":6731121544},{"date":"2026-07-24","current":-58.452905,"twenty":-32.317156,"median":-17.909322,"eighty":28.135623,"marketCap":7709313308},{"date":"2026-07-31","current":-54.750665,"twenty":-32.226362,"median":-17.873419,"eighty":28.196225,"marketCap":7234745026},{"date":"2026-08-07","current":-58.667923,"twenty":-32.226362,"median":-17.873419,"eighty":28.196225,"marketCap":7767423709},{"date":"2026-08-14","current":-59.543518,"twenty":-32.226362,"median":-17.873419,"eighty":28.196225,"marketCap":7893329580},{"date":"2026-08-21","current":-59.630914,"twenty":-32.384426,"median":-17.873419,"eighty":28.196225,"marketCap":7922384781},{"date":"2026-08-28","current":-40.912897,"twenty":-32.907641,"median":-17.873419,"eighty":28.196225,"marketCap":8396953062},{"date":"2026-09-04","current":-41.368181,"twenty":-34.387352,"median":-17.873419,"eighty":28.196225,"marketCap":8493803732},{"date":"2026-09-09","current":-39.795045,"twenty":-34.670805,"median":-17.873419,"eighty":28.196225,"marketCap":8183881589}],"updateTime":1789034692722},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"09966\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662033496","title":"Why Alphamab Oncology (SEHK:9966) Is Up 9.2% After Priority Review For Anbenitamab In HER2 Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033496","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033496?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:29","pubTimestamp":1787858983,"startTime":"0","endTime":"0","summary":"Alphamab Oncology recently reported half-year 2026 results showing CNY 271.24 million in sales and a net loss of CNY 40.46 million, while also securing Chinese priority review for multiple Anbenitamab new drug applications in HER2-positive breast cancer.\nThe acceptance of these Anbenitamab applications, backed by a head-to-head phase III trial in advanced HER2-positive breast cancer, marks a rare case where a bispecific antibody combination outperformed the long-standing THP standard regimen...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/why-alphamab-oncology-sehk9966-is-up-92-after-priority-revie","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-9966/alphamab-oncology-shares/news/why-alphamab-oncology-sehk9966-is-up-92-after-priority-revie","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169611235","title":"Alphamab Oncology Reports RMB40.46 Million 1H26 Loss Amid 15% Revenue Drop; Cash at RMB1.43 Billion Supports Expanding Oncology Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1169611235","media":"Bulletin Express","labels":["dataReport","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169611235?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:21","pubTimestamp":1787840514,"startTime":"0","endTime":"0","summary":"Alphamab Oncology released unaudited results for the six months ended 30 June 2026, showing a return to red ink as revenue contracted and royalty income softened, while research and development (R&D)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alphamab Oncology Reports RMB40.46 Million 1H26 Loss Amid 15% Revenue Drop; Cash at RMB1.43 Billion Supports Expanding Oncology Pipeline","news_tag":"dataReport,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662608309","title":"Alphamab Oncology Swings to FY26 H1 Loss of RMB 40.46 Million; Revenue Falls 15.09% to RMB 271.24 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2662608309","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662608309?lang=en_us&edition=fundamental","pubTime":"2026-08-27 22:03","pubTimestamp":1787839411,"startTime":"0","endTime":"0","summary":"Alphamab Oncology swings to FY26 H1 loss of RMB 40.46 million; revenue falls 15.09% to RMB 271.24 millionAlphamab Oncology posted a loss of RMB 40.46 million, swinging from a profit of RMB 21.58 milli","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260827:nNDL6fG19l:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136334991","title":"HK Movers | Biotech Stocks Jump. CANSINOBIO Surges 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136334991","media":"Tiger Newspress","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136334991?lang=en_us&edition=fundamental","pubTime":"2026-08-26 09:47","pubTimestamp":1787708820,"startTime":"0","endTime":"0","summary":"Biotech stocks jumped in Hong Kong market. CANSINOBIO surged 17%; Innovent Bio up 11%; Akeso up over 8%; Everest Med up 7%.On the news front, $CANSINOBIO(06185)$ announced on August 25 that its...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"330240692f324d079ccf839d9e4180bf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","09995","02359","02268","09688","02137","01672","02269","09606","06606","03347","03759","06978"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1175281752","title":"Alphamab's KN026 Combination Therapy for First-Line HER2-Positive Advanced Breast Cancer Receives NMPA Filing Acceptance","url":"https://stock-news.laohu8.com/highlight/detail?id=1175281752","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1175281752?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:06","pubTimestamp":1787047597,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) has announced that the New Drug Application (NDA) for anitumomab (trade name: Enituo, development code: KN026) in combination with docetaxel injection (albumin-bound) (HB1801) for...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","BK1161","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660146646","title":"Alphamab Oncology Says China NMPA Accepts Anbenitamab NDA for First-Line HER2+ Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660146646","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660146646?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:01","pubTimestamp":1787047294,"startTime":"0","endTime":"0","summary":"Alphamab Oncology says China NMPA accepts Anbenitamab NDA for first-line HER2+ advanced breast cancerChina’s NMPA accepted an NDA for anbenitamab (KN026) plus albumin-bound docetaxel HB1801 in first-l","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8jzLgj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","LU0315179316.USD","LU2039709279.SGD","HK0000165453.HKD","LU0072913022.USD","LU1152091754.HKD","BK1161","IE00BZ08YS42.EUR","LU0140636845.USD","BK1521","LU1226288253.USD","IE00BZ08YT58.USD","SG9999004220.SGD","IE00B5MMRT66.SGD","LU1807302812.USD","IE00B543WZ88.USD","LU0314109678.HKD","IE00B031HY20.USD","LU0501845795.SGD","01093","09966","BK1574","LU1328277881.USD","BK1191","LU1226287529.USD","LU1226287875.USD","IE0008368742.USD","LU1226288170.HKD","LU1993786604.SGD","LU1008478684.HKD","LU0067412154.USD","LU0880133367.SGD","LU1813983027.USD","KURE","LU1152091168.USD","IE0008369823.USD","LU0326950275.SGD","LU1960683339.HKD","LU1951186391.HKD","IE00BZ08YR35.GBP","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660466130","title":"Alphamab Oncology - Nmpa Accepts Nda for Anbenitamab (Kn026) with Hb1801 for Her2+ Advanced Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660466130","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660466130?lang=en_us&edition=fundamental","pubTime":"2026-08-18 18:00","pubTimestamp":1787047230,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44F0FD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658920308","title":"Alphamab Oncology Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2658920308","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658920308?lang=en_us&edition=fundamental","pubTime":"2026-08-12 16:36","pubTimestamp":1786523777,"startTime":"0","endTime":"0","summary":"Alphamab Oncology schedules board meeting to review interim resultsAlphamab Oncology scheduled a board meeting for Aug. 27, 2026 to review interim results for the six months ended June 30, 2026.Discla","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL4YBHQZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657084510","title":"Alphamab Oncology Licenses Cancer Drug Candidate to Pathos AI for Up to $2.09 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2657084510","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657084510?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:04","pubTimestamp":1785924260,"startTime":"0","endTime":"0","summary":"Alphamab Oncology's  wholly owned subsidiary, Jiangsu Alphamab Biopharmaceuticals, has granted Pathos AI an exclusive license to develop and commercialize cancer drug JSKN016 outside mainland China, Hong Kong, Macau and Taiwan, in a deal worth up to $2.09 billion.Under the agreement, Alphamab will receive a $125 million upfront payment and is eligible for additional milestone payments and tiered royalties based on sales in the licensed markets, according to a Hong Kong bourse filing.As part of the deal, Pathos AI granted Alphamab an option to invest up to $62.5 million in its preferred shares.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIX","CHAT","AIPO","VTHR","BK1161","09966","BK1574","QTOC","ARTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135953507","title":"Alphamab Oncology (ALPHAMAB-B) Reports Stable Share Capital and Option Movements for July 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1135953507","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135953507?lang=en_us&edition=fundamental","pubTime":"2026-08-05 17:29","pubTimestamp":1785922177,"startTime":"0","endTime":"0","summary":"Alphamab Oncology filed its monthly return to Hong Kong Exchanges and Clearing Limited for the period ended 31 July 2026. The filing shows no changes in either authorised or issued share capital...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558078","title":"CSPC Pharma Unit, Alphamab Oncology's Breast Cancer Drug Application Granted Priority Review in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558078","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656558078?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:34","pubTimestamp":1785843297,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical  said a new drug application for Anbenitamab was accepted by China's National Medical Products Administration, according to a Tuesday Hong Kong bourse filing.The application for Anbenitamab, co-developed by Shanghai JMT-Bio Technology, a unit of the company, and Alphamab Oncology , has also been included in the priority review and approval procedures.The indication for the application is Anbenitamab in combination with docetaxel  ± carboplatin as neoadjuvant therapy to treat breast cancer in adults.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1951186391.HKD","BK1515","BK1574","01093","IE00B543WZ88.USD","LU0067412154.USD","IE00BZ08YR35.GBP","LU1226287875.USD","IE00BZ08YS42.EUR","LU0326950275.SGD","LU1152091754.HKD","LU1226287529.USD","BK1521","LU0315179316.USD","IE0008368742.USD","LU1226288253.USD","LU2039709279.SGD","LU1152091168.USD","BK1161","IE00B5MMRT66.SGD","BK1191","LU0501845795.SGD","LU1008478684.HKD","SG9999004220.SGD","KURE","LU1328277881.USD","LU1960683339.HKD","LU0072913022.USD","HK0000165453.HKD","LU1813983027.USD","LU0880133367.SGD","IE00BZ08YT58.USD","IE00B031HY20.USD","LU1226288170.HKD","09966","LU0140636845.USD","LU1807302812.USD","LU1993786604.SGD","LU1226287792.SGD","LU0314109678.HKD","IE0008369823.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116442889","title":"ALPHAMAB-B's Novel Drug Application for Anniutuo (KN026) in HER2-Positive Breast Cancer Neoadjuvant Therapy Accepted by Chinese Regulator","url":"https://stock-news.laohu8.com/highlight/detail?id=1116442889","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116442889?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:11","pubTimestamp":1785838261,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966.HK) announced that the New Drug Application (NDA) for Anniutuo (brand name: Ennituo®, development code: KN026), developed in collaboration with CSPC Pharmaceutical Group (01093.HK)...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","IPOS","09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100652556","title":"Alphamab Oncology receives NMPA priority review for Anbenitamab NDA in neoadjuvant HER2+ breast-cancer therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=1100652556","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100652556?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:06","pubTimestamp":1785837961,"startTime":"0","endTime":"0","summary":"Alphamab Oncology announced that China’s National Medical Products Administration (NMPA) has accepted, and granted priority review status to, the new drug application (NDA) for Anbenitamab (trade...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656153495","title":"Alphamab Oncology Says NMPA Accepts NDA for Anbenitamab (kn026)","url":"https://stock-news.laohu8.com/highlight/detail?id=2656153495","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656153495?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:04","pubTimestamp":1785837881,"startTime":"0","endTime":"0","summary":"BRIEF-Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)Aug 4 (Reuters)-Alphamab Oncology9966.HK:NMPA ACCEPTS NDA FOR ANBENITAMAB (KN026) AS NEOADJUVANT HER2+ BREAST CANCER TREATMENTFurther company coverage:9966.HK","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44107H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1813983027.USD","BK1521","09966","BK1515","LU1152091754.HKD","IE0008369823.USD","SG9999004220.SGD","IE00BZ08YT58.USD","IE0008368742.USD","LU1226288253.USD","KURE","LU0880133367.SGD","LU0072913022.USD","LU1226287529.USD","LU1960683339.HKD","LU0501845795.SGD","HK0000165453.HKD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","01093","LU0140636845.USD","LU1951186391.HKD","IE00BZ08YS42.EUR","LU1807302812.USD","LU2039709279.SGD","LU0067412154.USD","BK1161","LU0315179316.USD","LU1226287792.SGD","BK1574","LU1328277881.USD","LU0326950275.SGD","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1226288170.HKD","BK1191","LU1993786604.SGD","LU0314109678.HKD","LU1008478684.HKD","LU1152091168.USD","LU1226287875.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656343715","title":"Alphamab Oncology - Nmpa Accepts Nda for Anbenitamab (Kn026) as Neoadjuvant Her2+ Breast Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2656343715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656343715?lang=en_us&edition=fundamental","pubTime":"2026-08-04 18:01","pubTimestamp":1785837662,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN44107H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656754582","title":"HK-Listed Alphamab Hits 2-Month High on Breast Cancer Drug Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2656754582","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656754582?lang=en_us&edition=fundamental","pubTime":"2026-08-04 13:58","pubTimestamp":1785823091,"startTime":"0","endTime":"0","summary":"BUZZ-HK-listed Alphamab hits 2-month high on breast cancer drug licensing deal** Shares of Alphamab Oncology9966.HKjump as much as 12.8% to HK$8.35, their highest point since June 2** Stock last up 5.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL1N44104T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","09966","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145569255","title":"ALPHAMAB-B Surges Over 12% in Morning Trade Following $2.1 Billion TROP2/HER3 Dual Antibody ADC Export Licensing Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=1145569255","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145569255?lang=en_us&edition=fundamental","pubTime":"2026-08-04 10:02","pubTimestamp":1785808931,"startTime":"0","endTime":"0","summary":"ALPHAMAB-B (09966) saw its stock price surge more than 12% during early trading hours, reaching a high of 8.32 Hong Kong dollars with a trading volume of 7.62 million Hong Kong dollars. As of the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09966","BK1574","NETL","BK4080","ADC","BK1161","BK4231"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588482","title":"Alphamab Oncology - Jiangsu Alphamab to Receive $125 Mln Upfront, up to $2.09 Bln Total from Pathos AI","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588482?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:00","pubTimestamp":1785801650,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4401MK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["09966","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588417","title":"Alphamab Oncology - Unit Granted Pathos AI Exclusive License to Commercialize Jskn016 in Territories Outside Chinese Mainland, HK, Macau, Taiwan","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588417","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588417?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:00","pubTimestamp":1785801650,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4401MK:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","09966","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656588104","title":"Alphamab Oncology Licenses Jskn016 Ex-China Rights to Pathos AI for up to USD 2.09 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2656588104","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656588104?lang=en_us&edition=fundamental","pubTime":"2026-08-04 08:00","pubTimestamp":1785801649,"startTime":"0","endTime":"0","summary":"Alphamab Oncology licenses JSKN016 ex-China rights to Pathos AI for up to USD 2.09 billionAlphamab Oncology licensed JSKN016 to Pathos AI on Aug. 3, 2026 for development, manufacturing, commercializat","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL3tV1k3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1161","09966"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":2,"totalSize":141,"code":"91000000","status":"200"}]}}